Europe Clot Management Devices Market By Product Type (Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis devices, Neurovascular Embolectomy Devices), End User (Hospitals, Diagnostic Centers)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Clot Management Devices Market
Market Report Description
As per the World Health Organisation (WHO), more than 17 million people die annually from cardiovascular diseases. The main reason for cardiovascular diseases are increasing consumption of tobacco products, physical inactivity, changes in diet plans, air pollution and work pressure. Blood Clotting also known as coagulation is the body?s response to an injury to prevent bleeding.
However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Increase in the clinical treatment of the cardiovascular disease and appearance of artificial organs such as wearable kidneys or lungs is growing the adoption of percutaneous devices instead of open surgical procedures.
It is expected that the growth of the clot management device market will also increase with the increase in the adaption of percutaneous devices. Clot Management devices are used for the treatment of coronary thrombosis, periphery artery, arteriovenous, neurovascular and DVT. Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters.
Based on End user Type, the market is segmented into Hospitals and Diagnostic Centres. Based on Country, Europe Clot Management Devices market is segmented into Germany, UK, France, Russia, Spain, Italy and Rest of Europe. Germany remained the dominant Country in the Europe Clot Management Devices market in 2015. France and Russia would witness promising CAGR during the forecast period (2016-2022).
The report covers the analysis of key stake holders of the Clot Management Devices market. Key companies profiled in the report include Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.
Global Clot Management Devices Market (2016-2022)
North America Clot Management Devices Market (2016-2022)
Asia Pacific Clot Management Devices Market (2016-2022)